Delgocitinib for the treatment of patients with moderate to severe chronic hand eczema

8 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Zanubrutinib for the treatment of patients with relapsed or refractory mantle cell lymphoma

10 July 2025 - NICE has published final evidence-based recommendations on the use of zanubrutinib for the treatment of adults ...

Read more →

Albanese should consider tweaks to PBS to avoid Trump tariff: CSL chair

9 July 2025 - Donald Trump’s move to ramp up tariffs on medicines and copper has sparked alarm among government ...

Read more →

PBS ‘not on the table’ in battle for pharmaceutical tariff exemption, despite lobbying

9 July 2025 - The threat of global 200 per cent tariffs on pharmaceutical products presents a challenge to Australia’s drug ...

Read more →

Will miracle HIV drug go on the PBS?

5 July 2025 - A new twice yearly antiviral injection that can prevent HIV is likely to be approved soon in ...

Read more →

Garadacimab for the prevention of recurrent attacks of hereditary angioedema in patients 12 years of age and older

2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Quebec implements public reimbursement of Pluvicto - a defining milestone for radioligand therapy in Canada

3 July 2025 - Pluvicto now publicly funded in provinces covering most Canadians, offering renewed hope to those facing progressive PSMA ...

Read more →

Teprotumumab for the treatment of patients with thyroid eye disease

2 July 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Public Summary Documents - March 2025 PBAC meeting

4 July 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the March 2025 ...

Read more →

Release of provisional recommendations for expert advisory committees

1 July 2025 - We’re improving our processes, so that people can understand the outcome of expert advice to PHARMAC earlier. ...

Read more →

Top level push for taxpayer funding of weight loss drugs gathers pace

3 July 2025 - Pharma giants are sweating on the results of a federal government request for guidance on adding weight ...

Read more →

Big pharma calls out Australia’s ‘freeloading’ on US medicine

3 July 2025 - American pharmaceutical manufacturers have ramped up pressure on Donald Trump to take action against Australia over its ...

Read more →

Calls for 'missing piece' menopause drug to be added to the PBS

2 July 2025 - A key treatment which could help around one million middle-aged Australian women remains unaffordable to many ...

Read more →

Life-saving breast cancer drug now cheaper thanks to expansion of the PBS

1 July 2025 - A potentially life-saving treatment for early-stage breast cancer will become much more affordable for hundreds of ...

Read more →

Adagrasib for adults with previously treated, advanced, KRAS G12C mutation positive non-small-cell lung cancer

2 July 2025 - NICE is unable to make a recommendation on the use of adagrasib (Krazati) for the second-line treatment ...

Read more →